Skip to Content

Watson 667 (Divalproex Sodium Delayed Release 500 mg)

Pill with imprint Watson 667 is Red, Elliptical / Oval and has been identified as Divalproex Sodium Delayed Release 500 mg. It is supplied by Watson Laboratories, Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Watson 667

Divalproex Sodium Delayed Release

Imprint
Watson 667
Strength
500 mg
Color
Red
Size
19.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
62037-0667
Inactive Ingredients
candelilla wax, cellacefate, silicon dioxide colloidal, croscarmellose sodium, dextrates, FD&C Red No. 40, hydroxypropyl cellulose, hypromellose 2910 (15 mPa.s), ferrosoferric oxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, propylene glycol, silicon dioxide, titanium dioxide, triacetin, aluminum oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "Watson 667"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.